PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis

Human Molecular Genetics

Volumn 22, Issue 17, 2013, Pages 3477-3484

  Eschbach, Judith ^a   Schwalenstö cker, Birgit ^a   Soyal, Selma M ^b   Bayer, Hanna ^a   Wiesner, Diana ^a   Akimoto, Chizuru ^c   Nilsson, Ann Charloth ^c   Birve, Anna ^c   Meyer, Thomas ^d   Dupuis, Luc ^e,f   Danzer, Karin M ^a   Andersen, Peter M ^a,c   Witting, Anke ^a   Ludolph, Albert C ^a   Patsch, Wolfgang ^b   Weydt, Patrick ^a  

^a UNIVERSITY OF ULM   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UMEÅ UNIVERSITY   (Sweden)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e INSERM   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; VASCULOTROPIN A;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SEX LINKAGE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TRANSGENIC MOUSE;

EID: 84881587124     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt202     Document Type: Article

References (44)

1. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Burrell, J.R. and Zoing, M.C. (2011) Amyotrophic lateral sclerosis. Lancet, 377, 942-955.
2. Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R.J., Millul, A., Benn, E., Beghi, E. for EURALS (2010) Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatr., 81, 385-390.
3. Heiman-Patterson, T.D., Deitch, J.S., Blankenhorn, E.P., Erwin, K.L., Perreault, M.J., Alexander, B.K., Byers, N., Toman, I., Alexander, G.M. (2005) Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci., 236, 1-7.
4. Andersen, P.M., Al-Chalabi, A. (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know. Nat. Rev. Neurol., 7, 603-615.
5. Finck, B.N. (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest., 116, 615-622.
6. Tsunemi, T., Ashe, T.D., Morrison, B.E., Soriano, K.R., Au, J., Roque, R.A.V., Lazarowski, E.R., Damian, V.A., Masliah, E., La Spada, A.R. (2012) PGC-1 rescues huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci. Trans. Med., 4, 142ra97-142ra97.
7. Arany, Z., Foo, S.-Y., Ma, Y., Ruas, J.L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S.M. et al. (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1a. Nature, 451, 1008-1012.
8. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators. Cell, 127, 397-408.
9. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman, B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92, 829-839.
10. Soyal, S.M., Felder, T.K., Auer, S., Hahne, P., Oberkofler, H., Witting, A., Paulmichl, M., Landwehrmeyer, G.B., Weydt, P., Patsch, W., et al. (2012)A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum. Mol. Genet., 21, 3461-3473.
11. Thau, N., Knippenberg, S., Körner, S., Rath, K.J., Dengler, R., Petri, S. (2012) Decreased mRNA expression of PGC-1a and PGC-1a-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. doi:10.1097/NEN.0b013e318275df4b.
12. Zhao, W., Varghese, M., Yemul, S., Pan, Y., Cheng, A., Marano, P., Hassan, S., Vempati, P., Chen, F., Qian, X., et al. (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1a) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener., 6, 51.
13. Da Cruz, S., Parone, P.A., Lopes, V.S., Lillo, C., McAlonis-Downes, M., Lee, S.K., Vetto, A.P., Petrosyan, S., Marsala, M., Murphy, A.N., et al. (2012) Elevated PGC-1a activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab., 15, 778-786.
14. Liang, H., Ward, W.F., Jang, Y.C., Bhattacharya, A., Bokov, A.F., Li, Y., Jernigan, A., Richardson, A., Van Remmen, H. (2011) PGC-1a protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve, 44, 947-956.
15. Brooks, B.R., Miller, R.G., Swash, M., Munsat, T.L., World Federation of Neurology Research Group on Motor Neuron Diseases. (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Other Motor Neuron Disord., 1, 293- 299.
16. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772-1775.
17. Lin, J., Wu, P.-H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.-Y., Mootha, V.K., Jäger, S., Vianna, C.R., Reznick, R.M., et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1a null mice. Cell, 119, 121-135.
18. Leone, T.C., Lehman, J.J., Finck, B.N., Schaeffer, P.J., Wende, A.R., Boudina, S., Courtois, M., Wozniak, D.F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) PGC-1a deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol., 3, e101.
19. Róna-Vörös, K., Weydt, P. (2010) The role of PGC-1a in the pathogenesis of neurodegenerative disorders. Curr. Drug Targets, 11, 1262-1269.
20. Chang, J.S., Fernand, V., Zhang, Y., Shin, J., Jun, H.J., Joshi, Y., Gettys, T.W. (2012) NT-PGC-1 protein is sufficient to link 3-adrenergic receptor activation to transcriptional and physiological components of adaptive thermogenesis. J. Biol. Chem., 287, 9100-9111.
21. Szalardy, L., Zadori, D., Plangar, I., Vecsei, L., Weydt, P., Ludolph, A., Klivényi, P., Kovacs, G. (2013) Neuropathology of partial PGC-1a deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases. Neurodegener. Dis., doi:10.1159/ 000346267.
22. Weydt, P., Hong, S., Kliot, M.,Möller, T. (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport, 14, 1051.
23. Boillee, S. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389-1392.
24. Ruas, J.L., White, J.P., Rao, R.R., Kleiner, S., Brannan, K.T., Harrison, B.C., Greene, N.P., Wu, J., Estall, J.L., Irving, B.A., et al. (2012) A PGC-1a isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell, 151, 1319-1331.
25. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet., 34, 383-394.
26. Fernández-Santiago, R., Sharma, M., Mueller, J.C., Gohlke, H., Illig, T., Anneser, J., Münch, C., Ludolph, A., Kamm, C., Gasser, T. (2006) Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. Neurology, 66, 1929-1931.
27. Azzouz, M., Ralph, G.S., Storkebaum, E., Walmsley, L.E., Mitrophanous, K.A., Kingsman, S.M., Carmeliet, P., Mazarakis, N.D. (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429, 413-417.
28. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.-P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W.Y., De Mol, M., et al. (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci., 8, 85-92.
29. Vande Velde, C., Cleveland, D.W. (2005) VEGF: multitasking in ALS. Nat. Neuroscience, 8, 5-7.
30. Xie, Y., Weydt, P., Howland, D.S., Kliot, M., Mö ller, T. (2004) Inflammatory mediators and growth factors in the spinal cord ofG93ASOD1 rats. Neuroreport, 15, 2513-2516.
31. Shiota, M., Yokomizo, A., Tada, Y., Inokuchi, J., Tatsugami, K., Kuroiwa, K., Uchiumi, T., Fujimoto, N., Seki, N., Naito, S. (2009) Peroxisome proliferator-activated receptor coactivator-1 interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol. Endocrinol., 24, 114-127.
32. Tcherepanova, I. (2000) Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J .Biol. Chem., 275, 16302-16308.
33. Farre, D. (2003) Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res., 31, 3651-3653.
34. Herman, J.P., Jullien, N., Guillen, S., Enjalbert, A., Pellegrini, I., Franc, J.L. (2012) Research resource: a genome-wide study identifies potential new target genes for POU1F1. Mol. Endocrinol., 26, 1455-1463.
35. Alvarez-Fischer, D., Fuchs, J., Castagner, F., Stettler, O., Massiani- Beaudoin, O., Moya, K.L., Bouillot, C., Oertel, W.H., Lombés, A., Faigle, W., et al. (2011) Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat. Neurosci., 14, 1260-1266.
36. Voliva, C.F., Aronheim, A., Walker, M.D., Peterlin, B.M. (1992) B-cell factor 1 is required for optimal expression of the DRA promoter in B cells. Mol. Cell. Biol., 12, 2383-2390.
37. Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M.-L.T., Xiao, T., Papp, A., Wang, D., et al. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl Acad. Sci. USA, 104, 20552-20557.
38. Sopher, B.L., Thomas, P.S., LaFevre-Bernt, M.A., Holm, I.E., Wilke, S.A., Ware, C.B., Jin, L.-W., Libby, R.T., Ellerby, L.M., LaSpada, A.R. (2004) Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron, 41, 687-699.
39. Dupuis, L. (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl Acad. Sci. USA, 101, 11159-11164.
40. Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K.A., Laird, A.S., Peeters, E., Philips, T., Goris, A., Dubois, B.E.N.E.D., et al. (2012) EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med., 18, 1418-1422.
41. Fergani, A., Eschbach, J., Oudart, H., Larmet, Y., Schwalenstocker, B., Ludolph, A.C., Loeffler, J.-P., Dupuis, L. (2011)Amutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol. Neurodegener., 6, 26.
42. Zhang, Y., Huypens, P., Adamson, A.W., Chang, J.S., Henagan, T.M., Boudreau, A., Lenard, N.R., Burk, D., Klein, J., Perwitz, N., et al. (2009) Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J. Biol. Chem., 284, 32813-32826.
43. Dupuis, L., Fergani, A., Braunstein, K.E., Eschbach, J., Holl, N., René, F., de Aguilar, J.-L.G., Zoerner, B., Schwalenstocker, B., Ludolph, A.C., et al. (2009) Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp. Neurol., 215, 146-152.
44. Felder, T.K., Soyal, S.M., Oberkofler, H., Hahne, P., Auer, S., Weiss, R., Gadermaier, G., Miller, K., Krempler, F., Esterbauer, H., et al. (2011) Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver. J. Biol. Chem., 286, 42923-42936.